Lilly Gets PTAB To Review 6 Teva Migraine Biologic Patents
The Patent Trial and Appeal Board has agreed to review six patents covering Teva Pharmaceuticals' migraine biologic Ajovy over the last week, following a challenge from Eli Lilly & Co....To view the full article, register now.
Already a subscriber? Click here to view full article